UniProtKB/Swiss-Prot Q14566 : Variant p.Cys158Tyr
DNA replication licensing factor MCM6
Gene: MCM6
Feedback ?
Variant information
Variant position:
158
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:
US
The variants are classified into three categories: LP/P, LB/B and US.LP/P: likely pathogenic or pathogenic. LB/B: likely benign or benign. US: uncertain significance
Residue change:
From Cysteine (C) to Tyrosine (Y) at position 158 (C158Y, p.Cys158Tyr).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:
Change from medium size and polar (C) to large size and aromatic (Y)
The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:
-2
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another: Lowest score: -4 (low probability of substitution).Highest score: 11 (high probability of substitution). More information can be found on the following page
Variant description:
Found in patients with microcephaly, developmental delay, typical facial characteristics, endocrine disorders, feeding difficulties and urogenital anomalies; uncertain significance; impairs cell proliferation and ciliogenesis.
Any additional useful information about the variant.
Sequence information
Variant position:
158
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:
821
The length of the canonical sequence.
Location on the sequence:
SGQVVRTHPVHPELVSGTFL
C LDCQTVIRDVEQQFKYTQPN
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:
The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human SGQVVRTHPVHPELVSGTFLC LDCQTVIRDVEQQFKYTQPN
Mouse SGQVVRTHPVHPELVSGTFLC LDCQTVIKDVEQQFKYTQPN
Bovine SGQVVRTHPVHPELVSGTFLC LDCQTVIKDVEQQFKYTQPN
Caenorhabditis elegans AGQIVRTHPVHPELSRACFVC EDCGVTTRDVQQQFRYTQPT
Drosophila SGQVVRTHPVHPELVSGVFMC LDCQTEIRNVEQQFKFTNPT
Slime mold SGTVTRTSEVRPELVIGSFIC KDCNTSSLPIAQQFKYTEPT
Baker's yeast SGTVTRTSEVRPELYKASFTC DMCRAIVDNVEQSFKYTEPT
Fission yeast TGTVTRTSEVRPELAQGTFIC EECHTVVSNVEQAFRYTEPT
Sequence annotation in neighborhood:
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 821
DNA replication licensing factor MCM6
Beta strand
148 – 158
Literature citations
De novo MCM6 variants in neurodevelopmental disorders: a recognizable phenotype related to zinc binding residues.
Smits D.J.; Schot R.; Popescu C.A.; Dias K.R.; Ades L.; Briere L.C.; Sweetser D.A.; Kushima I.; Aleksic B.; Khan S.; Karageorgou V.; Ordonez N.; Sleutels F.J.G.T.; van der Kaay D.C.M.; Van Mol C.; Van Esch H.; Bertoli-Avella A.M.; Roscioli T.; Mancini G.M.S.;
Hum. Genet. 0:0-0(2023)
Cited for: VARIANTS SER-149; TYR-158; GLY-202 AND SER-239; CHARACTERIZATION OF VARIANT TYR-158;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.